Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma.

Clinical lung cancer - 1 Nov 2024

Demir Tarık, Araz Murat, Moloney Carolyn, Hendem Engin, Koçak Mehmet Zahid, Erman Mustafa, Baş Onur, Köstek Osman, Sever Nadiye, Karakaya Serdar, Zeynelgil Esra, Chung Liam Il-Young, Chae Young Kwang

Abstract excerpt

BACKGROUND: Invasive mucinous adenocarcinoma (IMA) is a rare histological subtype of lung invasive adenocarcinoma with unique clinical, radiological, histopathological, and genomic characteristics. There have been limited studies on the effectiveness of systemic therapy for lung IMA, with conflicting results reported. METHODS: We retrospectively investigated the medical records of patients diagnosed with lung...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma, Mucinous
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Capecitabine

Share to ErbB Receptors

Share to Lung Neoplasms

Share to Neoplasm Invasiveness

Share to Survival Rate

Share to Treatment Outcome

Source

Identifiers

PMID: 38871540
DOI: 10.1016/j.cllc.2024.05.004

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Efficacy of Systemic Treatments in Patients With Metastatic Lung Invasive Mucinous Adenocarcinoma.PMID 38871540Read ↗

Clinical course of stage IV invasive mucinous adenocarcinoma of the lung.Semantic proximity Read ↗

Pulmonary invasive mucinous adenocarcinoma.Semantic proximity Read ↗

Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update Summary.Semantic proximity Read ↗

Comparison of the immunotherapy efficacy between invasive mucinous and non-mucinous adenocarcinoma in advanced lung cancer patients with KRAS mutation: a retrospective study.Semantic proximity Read ↗

Clinical profile and outcomes of patients with Stage IV adenocarcinoma of lung: A tertiary cancer center experience.Semantic proximity Read ↗

Systemic approaches for multifocal bronchioloalveolar carcinoma: is there an appropriate target?Semantic proximity Read ↗

Efficacy of chemotherapy in epidermal growth factor receptor (EGFR) mutated metastatic pulmonary adenocarcinoma patients who had acquired resistance to first-line EGFR tyrosine kinase inhibitor (TKI).Semantic proximity Read ↗

Large Cell Neuroendocrine Carcinoma of the Lung: Clinico-Pathologic Features, Treatment, and Outcomes.Semantic proximity Read ↗

Prognostic factors for resected invasive mucinous lung adenocarcinoma: a systematic review and meta-analysis.Semantic proximity Read ↗

Comparison of Surgical Outcomes Between Invasive Mucinous and Non-Mucinous Lung Adenocarcinoma.Semantic proximity Read ↗

Comprehensive analysis of the clinicopathological features, targetable profile, and prognosis of mucinous adenocarcinoma of the lung.Semantic proximity Read ↗

Management of medically inoperable and tyrosine kinase inhibitor-naïve early-stage lung adenocarcinoma with epidermal growth factor receptor mutations: a retrospective multi-institutional analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.